Acellular Pertussis Booster in Adolescents Induces Th1 and Memory CD8+ T Cell Immune Response
Open Access
- 8 March 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (3) , e17271
Abstract
In a number of countries, whole cell pertussis vaccines (wcP) were replaced by acellular vaccines (aP) due to an improved reactogenicity profile. Pertussis immunization leads to specific antibody production with the help of CD4+ T cells. In earlier studies in infants and young children, wcP vaccines selectively induced a Th1 dominated immune response, whereas aP vaccines led to a Th2 biased response. To obtain data on Th1 or Th2 dominance of the immune response in adolescents receiving an aP booster immunization after a wcP or aP primary immunization, we analyzed the concentration of Th1 (IL-2, TNF-α, INF-γ) and Th2 (IL-4, IL-5, IL-10) cytokines in supernatants of lymphocyte cultures specifically stimulated with pertussis antigens. We also investigated the presence of cytotoxic T cell responses against the facultative intracellular bacterium Bordetella pertussis by quantifying pertussis-specific CD8+ T cell activation following the aP booster immunization. Here we show that the adolescent aP booster vaccination predominantly leads to a Th1 immune response based on IFNgamma secretion upon stimulation with pertussis antigen, irrespective of a prior whole cell or acellular primary vaccination. The vaccination also induces an increase in peripheral CD8+CD69+ activated pertussis-specific memory T cells four weeks after vaccination. The Th1 bias of this immune response could play a role for the decreased local reactogenicity of this adolescent aP booster immunization when compared to the preceding childhood acellular pertussis booster. Pertussis-specific CD8+ memory T cells may contribute to protection against clinical pertussis.Keywords
This publication has 27 references indexed in Scilit:
- Reactogenicity of Tetanus, Diphtheria, 5-Component Acellular Pertussis Vaccine Administered as a Sixth Consecutive Acellular Pertussis Vaccine Dose to AdolescentsThe Pediatric Infectious Disease Journal, 2010
- T- and B-Cell-Mediated Protection Induced by Novel, Live Attenuated Pertussis Vaccine in Mice. Cross Protection against ParapertussisPLOS ONE, 2010
- Cellular Immune Responses of Preterm Infants after Vaccination with Whole-Cell or Acellular Pertussis VaccinesClinical and Vaccine Immunology, 2010
- Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in InfantsClinical and Vaccine Immunology, 2009
- Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccinationVaccine, 2008
- Cellular Immunity in Adolescents and Adults following Acellular Pertussis Vaccine AdministrationClinical and Vaccine Immunology, 2007
- Identification of CD8+T Cell Epitopes in the Immediate Early 62 Protein (IE62) of Varicella‐Zoster Virus, and Evaluation of Frequency of CD8+T Cell Response to IE62, by Use of IE62 Peptides after Varicella VaccinationThe Journal of Infectious Diseases, 2003
- Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of ageThe Pediatric Infectious Disease Journal, 2001
- Long-Term Pertussis-Specific Immunity after Primary Vaccination with a Combined Diphtheria, Tetanus, Tricomponent Acellular Pertussis, and Hepatitis B Vaccine in Comparison with That after Natural InfectionInfection and Immunity, 2001
- Household Contact Study of Bordetella pertussis InfectionsClinical Infectious Diseases, 1995